Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Chong Wang, Zehu Yuan, Ruixue Hu, Fadi Li & Xiangpeng Yue. (2023) Association of SNPs within PTPN3 gene with wool production and growth traits in a dual-purpose sheep population. Animal Biotechnology 34:4, pages 1429-1435.
Read now
Read now
Brenson A. Jassim, Jianping Lin & Zhong-Yin Zhang. (2022) PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapy. Expert Opinion on Drug Discovery 17:8, pages 825-837.
Read now
Read now
Akhilesh Kumar Tamrakar, Chandan K Maurya & Amit K Rai. (2014) PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents 24:10, pages 1101-1115.
Read now
Read now
Masilamani Elizabeth Sobhia, Stanly Paul$suffix/text()$suffix/text(), Ranajit Shinde, Mrudula Potluri, Venkatesh Gundam, Amandeep Kaur & Thongtinlal Haokip. (2012) Protein tyrosine phosphatase inhibitors: a patent review (2002 – 2011). Expert Opinion on Therapeutic Patents 22:2, pages 125-153.
Read now
Read now
Elif
Ozkirimli Olmez & Burak Alakent. (2011) Alpha7 Helix Plays an Important Role in the Conformational Stability of PTP1B. Journal of Biomolecular Structure and Dynamics 28:5, pages 675-693.
Read now
Read now
Susana R. Pereira, Vítor M. Vasconcelos & Agostinho Antunes. (2011) The phosphoprotein phosphatase family of Ser/Thr phosphatases as principal targets of naturally occurring toxins. Critical Reviews in Toxicology 41:2, pages 83-110.
Read now
Read now
Marie Fridberg, Sofia Kjellström, Lola Anagnostaki, Ingela Skogvall, Tomas Mustelin, Thomas Wiebe, Jenny L. Persson, Michael Dictor & Anette Gjörloff Wingren. (2008) IMMUNOHISTOCHEMICAL ANALYSES OF PHOSPHATASES IN CHILDHOOD B-CELL LYMPHOMA: Lower Expression of PTEN and HePTP and Higher Number of Positive Cells for Nuclear SHP2 in B-Cell Lymphoma Cases Compared to Controls. Pediatric Hematology and Oncology 25:6, pages 528-540.
Read now
Read now
Marie Fridberg, Anna Servin, Lola Anagnostaki, Johan Linderoth, Mattias Berglund, Ola Söderberg, Gunilla Enblad, Anders Rosén, Tomas Mustelin, Mats Jerkeman, Jenny L. Persson & Anette Gjörloff Wingren. (2007) Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-β II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. Leukemia & Lymphoma 48:11, pages 2221-2232.
Read now
Read now
Articles from other publishers (70)
Hanfei Wang, Robert GastonJr.Jr., Kh Tanvir Ahmed, Gregory B. Dudley & Amy M. Barrios. (2023) Derivatives of the Fungal Natural Product Illudalic Acid Inhibit the Activity of Protein Histidine Phosphatase PHPT1. ChemMedChem 18:15.
Crossref
Crossref
Harvey F. Fulo, Nicole J. Rueb, Robert Gaston, Paratchata Batsomboon, Kh Tanvir Ahmed, Amy M. Barrios & Gregory B. Dudley. (2021) Synthesis of illudalic acid and analogous phosphatase inhibitors. Organic & Biomolecular Chemistry 19:48, pages 10596-10600.
Crossref
Crossref
Lester J Lambert, Stefan Grotegut, Maria Celeridad, Palak Gosalia, Laurent JS De Backer, Andrey A Bobkov, Sumeet Salaniwal, Thomas DY Chung, Fu-Yue Zeng, Ian Pass, Paul J Lombroso, Nicholas DP Cosford & Lutz Tautz. (2021) Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP). International Journal of Molecular Sciences 22:9, pages 4417.
Crossref
Crossref
Chiranjeev Sharma, Youllee Kim, Dohee Ahn & Sang J. Chung. (2021) Protein tyrosine phosphatases (PTPs) in diabetes: causes and therapeutic opportunities. Archives of Pharmacal Research 44:3, pages 310-321.
Crossref
Crossref
Alessandra V. S. Faria, Emanuella Maria Barreto Fonseca, Helon Guimarães Cordeiro, Stefano Piatto Clerici & Carmen Veríssima Ferreira-Halder. (2020) Low molecular weight protein tyrosine phosphatase as signaling hub of cancer hallmarks. Cellular and Molecular Life Sciences 78:4, pages 1263-1273.
Crossref
Crossref
Elena S. Ma & Amy M. Barrios. (2019) Rational design of a SHP-2 targeted, fluorogenic peptide substrate. Bioorganic & Medicinal Chemistry Letters 29:17, pages 2452-2454.
Crossref
Crossref
Phaedra Eleftheriou, Athina Geronikaki & Anthi Petrou. (2019) PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II. Current Topics in Medicinal Chemistry 19:4, pages 246-263.
Crossref
Crossref
George T. Lountos, Sreejith Raran-Kurussi, Bryan M. Zhao, Beverly K. Dyas, Terrence R. BurkeJrJr, Robert G. Ulrich & David S. Waugh. (2018) High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design. Acta Crystallographica Section D Structural Biology 74:10, pages 1015-1026.
Crossref
Crossref
Seon Young Lee, Wooil Kim, Young Geun Lee, Hyo Jin Kang, Sang-Hyun Lee, Sun Young Park, Jeong-Ki Min, Sang-Rae Lee & Sang J. Chung. (2017) Identification of sennoside A as a novel inhibitor of the slingshot (SSH) family proteins related to cancer metastasis. Pharmacological Research 119, pages 422-430.
Crossref
Crossref
Angel Bottini, Bainan Wu, Elisa Barile, Surya K. De, Marilisa Leone & Maurizio Pellecchia. (2016) High-Throughput Screening (HTS) by NMR Guided Identification of Novel Agents Targeting the Protein Docking Domain of YopH. ChemMedChem 11:8, pages 919-927.
Crossref
Crossref
Colin Levy, James Adams & Lydia Tabernero. 2016. Protein Tyrosine Phosphatases. Protein Tyrosine Phosphatases
155
180
.
Kendra K. Bence. 2016. Protein Tyrosine Phosphatases in Cancer. Protein Tyrosine Phosphatases in Cancer
307
333
.
Lutz Tautz, Yotis A. Senis, Cécile Oury & Souad Rahmouni. (2015) Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy. Bioorganic & Medicinal Chemistry 23:12, pages 2786-2797.
Crossref
Crossref
Kylie S. White, Gina Nicoletti & Robert Borland. (2014) Nitropropenyl Benzodioxole, An Anti-Infective Agent with Action as a Protein Tyrosine Phosphatase Inhibitor. The Open Medicinal Chemistry Journal 8:1, pages 1-16.
Crossref
Crossref
Lalima Gagan AhujaBalasubramanian Gopal. (2014) Bi-Domain Protein Tyrosine Phosphatases Reveal an Evolutionary Adaptation to Optimize Signal Transduction. Antioxidants & Redox Signaling 20:14, pages 2141-2159.
Crossref
Crossref
Katie R. Martin, Pooja Narang, José L. Medina-Franco, Nathalie Meurice & Jeffrey P. MacKeigan. (2014) Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery. Methods 65:2, pages 219-228.
Crossref
Crossref
Andreas Brunschweiger & Jonathan Hall. 2013. Medicinal Chemistry Approaches to Personalized Medicine. Medicinal Chemistry Approaches to Personalized Medicine
343
364
.
Tamanna Anwar & Samudrala Gourinath. (2013) Analysis of the Protein Phosphotome of Entamoeba histolytica Reveals an Intricate Phosphorylation Network. PLoS ONE 8:11, pages e78714.
Crossref
Crossref
Madhavi Muppirala, Vijay Gupta & Ghanshyam Swarup. (2013) Emerging role of tyrosine phosphatase, TCPTP, in the organelles of the early secretory pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1833:5, pages 1125-1132.
Crossref
Crossref
Stephanie M. Stanford, Michael F. Maestre, Amanda M. Campbell, Beatrix Bartok, William B. Kiosses, David L. Boyle, Heather A. Arnett, Tomas Mustelin, Gary S. Firestein & Nunzio Bottini. (2013) Protein Tyrosine Phosphatase Expression Profile of Rheumatoid Arthritis Fibroblast‐like Synoviocytes: A Novel Role of SH2 Domain–Containing Phosphatase 2 as a Modulator of Invasion and Survival. Arthritis & Rheumatism 65:5, pages 1171-1180.
Crossref
Crossref
Nilkanth G. Aher, Bhooshan Kafle & Hyeongjin Cho. (2013) Thiazolidinone Derivatives as Competitive Inhibitors of Protein Tyrosine Phosphatase 1B (PTP1B). Bulletin of the Korean Chemical Society 34:4, pages 1275-1277.
Crossref
Crossref
Souad Rahmouni, Laurence Delacroix, Wallace H. Liu & Lutz Tautz. 2013. Phosphatase Modulators. Phosphatase Modulators
241
270
.
Lutz Tautz & Eduard A. Sergienko. 2013. Phosphatase Modulators. Phosphatase Modulators
223
240
.
Lutz Tautz, David A. Critton & Stefan Grotegut. 2013. Phosphatase Modulators. Phosphatase Modulators
179
221
.
Manal Sarkis, Diem Ngan Tran, Stéphanie Kolb, Maria A. Miteva, Bruno O. Villoutreix, Christiane Garbay & Emmanuelle Braud. (2012) Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: Effect of dimerisation on phosphatase inhibition. Bioorganic & Medicinal Chemistry Letters 22:24, pages 7345-7350.
Crossref
Crossref
Katie R. Martin, Pooja Narang, Yong Xu, Audra L. Kauffman, Joachim Petit, H. Eric Xu, Nathalie Meurice & Jeffrey P. MacKeigan. (2012) Identification of Small Molecule Inhibitors of PTPσ through an Integrative Virtual and Biochemical Approach. PLoS ONE 7:11, pages e50217.
Crossref
Crossref
Stephanie M. StanfordRekha G. PanchalLogan M. WalkerDennis J. WuMatthew D. FalkSayantan MitraSagar S. DamleDavid RubleTeodora Kaltcheva, Sheng Zhang, Zhong-Yin Zhang, Sina BavariAmy M. Barrios & Nunzio Bottini. (2012) High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45. Proceedings of the National Academy of Sciences 109:35, pages 13972-13977.
Crossref
Crossref
Sarath Kumar Baskaran, Nabajyoti Goswami, Sudhagar Selvaraj, Velusamy Shanmuganathan Muthusamy & Baddireddi Subhadra Lakshmi. (2012) Molecular Dynamics Approach to Probe the Allosteric Inhibition of PTP1B by Chlorogenic and Cichoric Acid. Journal of Chemical Information and Modeling 52:8, pages 2004-2012.
Crossref
Crossref
Torkel Vang, Wallace H Liu, Laurence Delacroix, Shuangding Wu, Stefan Vasile, Russell Dahl, Li Yang, Lucia Musumeci, Dana Francis, Johannes Landskron, Kjetil Tasken, Michel L Tremblay, Benedicte A Lie, Rebecca Page, Tomas Mustelin, Souad Rahmouni, Robert C Rickert & Lutz Tautz. (2012) LYP inhibits T-cell activation when dissociated from CSK. Nature Chemical Biology 8:5, pages 437-446.
Crossref
Crossref
Suresh Thareja, Saurabh Aggarwal, T. R. Bhardwaj & Manoj Kumar. (2010) Protein Tyrosine Phosphatase 1B Inhibitors: A Molecular Level Legitimate Approach for the Management of Diabetes Mellitus. Medicinal Research Reviews 32:3, pages 459-517.
Crossref
Crossref
Eduard Sergienko, Jian Xu, Wallace H. Liu, Russell Dahl, David A. Critton, Ying Su, Brock T. Brown, Xochella Chan, Li Yang, Ekaterina V. Bobkova, Stefan Vasile, Hongbin Yuan, Justin Rascon, Sharon Colayco, Shyama Sidique, Nicholas D. P. Cosford, Thomas D. Y. Chung, Tomas Mustelin, Rebecca Page, Paul J. Lombroso & Lutz Tautz. (2011) Inhibition of Hematopoietic Protein Tyrosine Phosphatase Augments and Prolongs ERK1/2 and p38 Activation. ACS Chemical Biology 7:2, pages 367-377.
Crossref
Crossref
Andreas Brunschweiger & Jonathan Hall. (2012) A Decade of the Human Genome Sequence-How Does the Medicinal Chemist Benefit?. ChemMedChem 7:2, pages 194-203.
Crossref
Crossref
Dara Ajay & M. Elizabeth Sobhia. (2011) Identification of novel, less toxic PTP-LAR inhibitors using in silico strategies: pharmacophore modeling, SADMET-based virtual screening and docking. Journal of Molecular Modeling 18:1, pages 187-201.
Crossref
Crossref
Steven Sheriff, Brett R. Beno, Weixu Zhai, Walter A. Kostich, Patricia A. McDonnell, Kevin Kish, Valentina Goldfarb, Mian Gao, Susan E. Kiefer, Joseph Yanchunas, Yanling Huang, Shuhao Shi, Shirong Zhu, Carolyn Dzierba, Joanne Bronson, John E. Macor, Kingsley K. Appiah, Ryan S. Westphal, Jonathan O’Connell & Samuel W. Gerritz. (2011) Small Molecule Receptor Protein Tyrosine Phosphatase γ (RPTPγ) Ligands That Inhibit Phosphatase Activity via Perturbation of the Tryptophan–Proline–Aspartate (WPD) Loop. Journal of Medicinal Chemistry 54:19, pages 6548-6562.
Crossref
Crossref
Dušica Vidović, Yuli Xie, Alison Rinderspacher, Shi-Xian Deng, Donald W. Landry, Caty Chung, Deborah H. Smith, Lutz Tautz & Stephan C. Schürer. (2011) Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype. Journal of Computer-Aided Molecular Design 25:9, pages 873-883.
Crossref
Crossref
Zhi-Hong Yu, Lan Chen, Li Wu, Sijiu Liu, Lina Wang & Zhong-Yin Zhang. (2011) Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening. Bioorganic & Medicinal Chemistry Letters 21:14, pages 4238-4242.
Crossref
Crossref
Ekaterina V. Bobkova, Wallace H. Liu, Sharon Colayco, Justin Rascon, Stefan Vasile, Carlton Gasior, David A. Critton, Xochella Chan, Russell Dahl, Ying Su, Eduard Sergienko, Thomas D. Y. Chung, Tomas Mustelin, Rebecca Page & Lutz Tautz. (2010) Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids. ACS Medicinal Chemistry Letters 2:2, pages 113-118.
Crossref
Crossref
Torkel Vang, Yuli Xie, Wallace H. Liu, Dušica Vidović, Yidong Liu, Shuangding Wu, Deborah H. Smith, Alison Rinderspacher, Caty Chung, Gangli Gong, Tomas Mustelin, Donald W. Landry, Robert C. Rickert, Stephan C. Schürer, Shi-Xian Deng & Lutz Tautz. (2010) Inhibition of Lymphoid Tyrosine Phosphatase by Benzofuran Salicylic Acids. Journal of Medicinal Chemistry 54:2, pages 562-571.
Crossref
Crossref
David A. Critton, Lutz Tautz & Rebecca Page. (2011) Visualizing Active-Site Dynamics in Single Crystals of HePTP: Opening of the WPD Loop Involves Coordinated Movement of the E Loop. Journal of Molecular Biology 405:3, pages 619-629.
Crossref
Crossref
Esther Jortzik, Sebastian Kehr & Katja Becker. 2011. Progress in Parasitology. Progress in Parasitology
93
120
.
Ry Y. Tweedie-Cullen, C. Sehwan Park & Isabelle M. Mansuy. 2011. Post-Translational Modifications in Health and Disease. Post-Translational Modifications in Health and Disease
233
257
.
Alastair J Barr. (2010) Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development. Future Medicinal Chemistry 2:10, pages 1563-1576.
Crossref
Crossref
Marilisa Leone, Elisa Barile, Jesus Vazquez, Angel Mei, Donald Guiney, Russel Dahl & Maurizio Pellecchia. (2010) NMR‐Based Design and Evaluation of Novel Bidentate Inhibitors of the Protein Tyrosine Phosphatase YopH. Chemical Biology & Drug Design 76:1, pages 10-16.
Crossref
Crossref
Willian F. Zambuzzi, Renato Milani & Anna Teti. (2010) Expanding the role of Src and protein-tyrosine phosphatases balance in modulating osteoblast metabolism: Lessons from mice. Biochimie 92:4, pages 327-332.
Crossref
Crossref
Shuangding Wu, Sofie Vossius, Souad Rahmouni, Ana V. Miletic, Torkel Vang, Jesus Vazquez-Rodriguez, Fabio Cerignoli, Yutaka Arimura, Scott Williams, Tikva Hayes, Michel Moutschen, Stefan Vasile, Maurizio Pellecchia, Tomas Mustelin & Lutz Tautz. (2009)
Multidentate Small-Molecule Inhibitors of
Vaccinia
H1-Related (VHR) Phosphatase Decrease Proliferation of Cervix Cancer Cells
. Journal of Medicinal Chemistry 52:21, pages 6716-6723.
Crossref
Crossref
Dušica Vidović & Stephan C. Schürer. (2009) Knowledge-Based Characterization of Similarity Relationships in the Human Protein−Tyrosine Phosphatase Family for Rational Inhibitor Design. Journal of Medicinal Chemistry 52:21, pages 6649-6659.
Crossref
Crossref
Rekha G. Panchal, Ricky L. Ulrich, Steven B. Bradfute, Douglas Lane, Gordon Ruthel, Tara A. Kenny, Patrick L. Iversen, Arthur O. Anderson, Rick Gussio, William C. Raschke & Sina Bavari. (2009) Reduced Expression of CD45 Protein-tyrosine Phosphatase Provides Protection against Anthrax Pathogenesis. Journal of Biological Chemistry 284:19, pages 12874-12885.
Crossref
Crossref
Shuangding Wu, Massimo Bottini, Robert C. Rickert, Tomas Mustelin & Lutz Tautz. (2009) In Silico Screening for PTPN22 Inhibitors: Active Hits from an Inactive Phosphatase Conformation. ChemMedChem 4:3, pages 440-444.
Crossref
Crossref
Alastair J. Barr, Emilie Ugochukwu, Wen Hwa Lee, Oliver N.F. King, Panagis Filippakopoulos, Ivan Alfano, Pavel Savitsky, Nicola A. Burgess-Brown, Susanne Müller & Stefan Knapp. (2009) Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome. Cell 136:2, pages 352-363.
Crossref
Crossref
Barbara Lejczak & Pawel Kafarski. 2009. Phosphorous Heterocycles I. Phosphorous Heterocycles I
31
63
.
Harshani R. Lawrence, Roberta Pireddu, Liwei Chen, Yunting Luo, Shen-Shu Sung, Ann Marie Szymanski, M. L. Richard Yip, Wayne C. Guida, Saïd M. Sebti, Jie Wu & Nicholas J. Lawrence. (2008) Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds. Journal of Medicinal Chemistry 51:16, pages 4948-4956.
Crossref
Crossref
Qing Ling, Yue Huang, Yueyang Zhou, Zhengliang Cai, Bing Xiong, Yahui Zhang, Lanping Ma, Xin Wang, Xin Li, Jia Li & Jingkang Shen. (2008) Illudalic acid as a potential LAR inhibitor: Synthesis, SAR, and preliminary studies on the mechanism of action. Bioorganic & Medicinal Chemistry 16:15, pages 7399-7409.
Crossref
Crossref
Ivano Bertini, Marco Fragai, Claudio Luchinat & Eleonora Talluri. (2008) Water‐Based Ligand Screening for Paramagnetic Metalloproteins. Angewandte Chemie International Edition 47:24, pages 4533-4537.
Crossref
Crossref
Ivano Bertini, Marco Fragai, Claudio Luchinat & Eleonora Talluri. (2008) Water‐Based Ligand Screening for Paramagnetic Metalloproteins. Angewandte Chemie 120:24, pages 4609-4613.
Crossref
Crossref
Dalia Berman-Golan, Shira Granot-Attas & Ari Elson. (2008) Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis. Cancer and Metastasis Reviews 27:2, pages 193-203.
Crossref
Crossref
Sayantan Mitra & Amy M. Barrios. (2008) Identifying Selective Protein Tyrosine Phosphatase Substrates and Inhibitors from a Fluorogenic, Combinatorial Peptide Library. ChemBioChem 9:8, pages 1216-1219.
Crossref
Crossref
Torkel VangAna V. MileticYutaka ArimuraLutz TautzRobert C. RickertTomas Mustelin. (2008) Protein Tyrosine Phosphatases in Autoimmunity. Annual Review of Immunology 26:1, pages 29-55.
Crossref
Crossref
Lydia Tabernero, A. Radu Aricescu, E. Yvonne Jones & Stefan E. Szedlacsek. (2008) Protein tyrosine phosphatases: structure–function relationships. The FEBS Journal 275:5, pages 867-882.
Crossref
Crossref
En-Chi Hsu, Yen-Cheng Lin, Chia-Shia Hung, Chiu-Jung Huang, Mei-Yi Lee, Shun-Chun Yang & Ling-Pai Ting. (2007) Suppression of hepatitis B viral gene expression by protein-tyrosine phosphatase PTPN3. Journal of Biomedical Science 14:6, pages 731-744.
Crossref
Crossref
Lutz Tautz & Tomas Mustelin. (2007) Strategies for developing protein tyrosine phosphatase inhibitors. Methods 42:3, pages 250-260.
Crossref
Crossref
Anthony C. Bishop, Xin-Yu Zhang & Anna Mari Lone. (2007) Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations. Methods 42:3, pages 278-288.
Crossref
Crossref
Jesus Vazquez, Lutz Tautz, Jennifer J. Ryan, Kristiina Vuori, Tomas Mustelin & Maurizio Pellecchia. (2007) Development of Molecular Probes for Second-Site Screening and Design of Protein Tyrosine Phosphatase Inhibitors. Journal of Medicinal Chemistry 50:9, pages 2137-2143.
Crossref
Crossref
Carmen V. Ferreira, Giselle Z. Justo, Ana C.S. Souza, Karla C.S. Queiroz, William F. Zambuzzi, Hiroshi Aoyama & Maikel P. Peppelenbosch. (2006) Natural compounds as a source of protein tyrosine phosphatase inhibitors: Application to the rational design of small-molecule derivatives. Biochimie 88:12, pages 1859-1873.
Crossref
Crossref
Alistair T.R. Sim, Russell I. Ludowyke & Nicole M. Verrills. (2006) Mast cell function: Regulation of degranulation by serine/threonine phosphatases. Pharmacology & Therapeutics 112:2, pages 425-439.
Crossref
Crossref
Christopher. A. McCulloch, Gregory P. Downey & Hani El-Gabalawy. (2006) Signalling platforms that modulate the inflammatory response: new targets for drug development. Nature Reviews Drug Discovery 5:10, pages 864-876.
Crossref
Crossref
Alastair J. Barr & Stefan Knapp. (2006) MAPK-specific tyrosine phosphatases: new targets for drug discovery?. Trends in Pharmacological Sciences 27:10, pages 525-530.
Crossref
Crossref
Tomas Mustelin. (2006) Are other protein tyrosine phosphatases than PTPN22 associated with autoimmunity?. Seminars in Immunology 18:4, pages 254-260.
Crossref
Crossref
Alastair J. Barr, Judit É. Debreczeni, Jeyanthy Eswaran & Stefan Knapp. (2006) Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-Å resolution. Proteins: Structure, Function, and Bioinformatics 63:4, pages 1132-1136.
Crossref
Crossref
Jeyanthy EswaranJens Peter von Kries, Brian MarsdenEmma LongmanJudit É. DebreczeniEmilie UgochukwuAndrew TurnbullWen Hwa LeeStefan KnappAlastair J. Barr. (2006) Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases. Biochemical Journal 395:3, pages 483-491.
Crossref
Crossref
Tomas Mustelin. 2006. Lymphocyte Signal Transduction. Lymphocyte Signal Transduction
53
72
.